0.31
-0.0144(-4.42%)
Currency In USD
| Previous Close | 0.33 |
| Open | 0.32 |
| Day High | 0.33 |
| Day Low | 0.3 |
| 52-Week High | 4 |
| 52-Week Low | 0.2 |
| Volume | 381,896 |
| Average Volume | 7.16M |
| Market Cap | 9.37M |
| PE | 0.66 |
| EPS | 0.47 |
| Moving Average 50 Days | 0.36 |
| Moving Average 200 Days | 0.98 |
| Change | -0.01 |
If you invested $1000 in Carmell Therapeutics Corporation (CTCX) since IPO date, it would be worth $31.91 as of February 05, 2025 at a share price of $0.311. Whereas If you bought $1000 worth of Carmell Therapeutics Corporation (CTCX) shares 3 years ago, it would be worth $32.07 as of February 05, 2025 at a share price of $0.311.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Carmell Announces Closing of Elevai Skincare Acquisition
GlobeNewswire Inc.
Jan 16, 2025 1:00 PM GMT
PITTSBURGH, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health (“Carmell”, the “Company”, “we”, “our”, or “us”), today announced the closing of the previously announced acq
Carmell Announces Closing of Previously Announced PIPE Investment from Existing and New Investors to Support Commercial Build-out
GlobeNewswire Inc.
Jan 03, 2025 1:00 PM GMT
PITTSBURGH, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health (“Carmell”, the “Company”, “we”, “our”, or “us”), today announced the closing of its previously announced pri
Carmell Announces Execution of Definitive Agreement to Acquire Elevai Skincare, a leader in Physician Dispensed Exosome Skin and Hair Care Products
GlobeNewswire Inc.
Jan 02, 2025 1:00 PM GMT
PITTSBURGH, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health (“Carmell”, the “Company”, “we”, “our”, or “us”), today announced that it entered into a definitive purchase